Top

Published in:

01-03-2013 | News item

Incretin mimetics potential link with pancreatic pre-cancer

Published in: Reactions Weekly | Issue 1/2013

Excerpt

The US FDA is investigating unpublished findings indicating potential links between the use of incetin mimetics and the risks of pancreatitis and pancreatic duct metaplasia in patients with type 2 diabetes. …

FDA. FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes. Internet Document : 15 Mar 2013. Available from: URL: http://www.fda.gov

Title: Incretin mimetics potential link with pancreatic pre-cancer
Publication date: 01-03-2013
Publisher: Springer International Publishing AG
Published in: Reactions Weekly / Issue 1/2013
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-2020-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incretin mimetics potential link with pancreatic pre-cancer

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Adalimumab

Vemurafenib

Butamirate

Fluoropyrimidine derivatives

Botulinum toxin A

Factor VIII comparative study sparks PRAC review